Skip to content

Clinical effect of Zolendronate for rotator cuff healing after arthroscopic repair

Clinical effect of Zolendronate for rotator cuff healing after arthroscopic repair

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005322
Enrollment
40
Registered
2020-08-21
Start date
2020-02-18
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hallym University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Rotator cuff tear involving supraspinatus or infraspinatus tendon with sized over 2 cm. 2) female > 65 years old or male >70 year old with BMD < -2.5 3) Who consent to the study 4) Follow-up duration over 6 months after surgery

Exclusion criteria

Exclusion criteria: 1) Previous surgical history on the same shoulder 2) Infectious or autoimmune or systemic skeletal disease 3) Rotator arthropathy, moderate to severe osteoarthritis, Rheumatoid arthritis 4) current anti-osteoporotic drug users including bisphophonate 5) Contraindicated patients with bisphophonate -hypersenstive to the bisphophonate - hypocalcemia - Pregenency - Kidney disease with Creatinine clearance rate <35mL/min

Design outcomes

Primary

MeasureTime frame
Integrity of repaired tendon on Magnetic resonance imaging

Secondary

MeasureTime frame
functional score (ASES, SST), range of motion, pain Visual Analogue Scale(VAS), satisfactory VAS

Countries

Korea, Republic of

Contacts

Public ContactYong-Beom Lee

Hallym University Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026